Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has provided an update.
Syntara Limited has announced the quotation of 4,760,900 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective August 29, 2025. This move indicates the company’s ongoing efforts to enhance its market presence and potentially attract more investors, which could have implications for its financial growth and stakeholder engagement.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 7,328,631
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$42.32M
For detailed information about SNT stock, go to TipRanks’ Stock Analysis page.